That chart shows that state being the lowest death toll both before and after ivermectin treatment, which would seem to point to some serious confounding factors in this analysis.

Not to mention dramatic changes else where as well, and that’s assuming this data is accurate. It’s also from very early in the pandemic, when we didn’t know as much generally. Plus correlation =! causation. Could be far better making behaviors there, or all kinds of other factors. That’s why you need randomized double blind clinical trials, done by experts. This arm chair “analysis” is just bad science.

To me, this kind of regional comparison, contrasting before and after Ivermectin was deployed as a treatment, has been the most convincing evidence that Ivermectin is an effective treatment.

This paper by Pierre Kory has graphs that clearly show the evolution of Covid cases and deaths across different states in Peru.

https://covid19criticalcare.com/wp-content/uploads/2020/11/F...

Convincing would be a large double blind controlled study.